跳至主要内容
临床试验/EUCTR2019-002002-43-ES
EUCTR2019-002002-43-ES进行中(未招募)1 期

Phase IV, unicentric, randomized and open study to confirm the decrease of the incidence of the surgical site infection after elective right hemicolectomy with anterographic mechanical preparation associated with oral and intravenous antibiotic therapy versus oral and intravenous antibiotic and versus only intravenous antibiotic

Fundación Instituto de Investigación Sanitaria Aragón0 个研究点目标入组 108 人开始时间: 2019年10月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients older than 18 years with surgical indication of right hemicolectomy who do not present any exclusion criteria.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 18

排除标准

  • 1. Patients under 18 years.
  • 2. Urgent colorectal resections.
  • 3. Patients presenting an occlusive or sub-occlusive condition at the time of surgery.
  • 4. Patient who does not meet the inclusion criteria in the intensified recovery program based on the RICA route (Intensified Recovery in Abdominal Surgery)
  • 5. Patients undergoing colonic resection that involve a location other than the right colon.
  • 6. Patients affected by intra-abdominal or distant infection prior to surgery.
  • 7. Patients who have been given antibiotics for any other indication during the two weeks prior to the intervention.
  • 8. Patient with inflammatory bowel disease.
  • 9. Pregnant or breastfeeding patient.
  • 10. Patients with immunity disorders or receiving immunosuppressive treatment or with synchronous neoplasms of other organs at the time of surgery.
  • 11. Previous history of allergy to erythromycin, neomycin or derivatives, as well as Citrafleet®.

研究者

相似试验

进行中(未招募)
不适用
A phase IV, open, randomized, controlled study to demonstrate the non-inferiority of co-administration of GSK Biologicals’ live attenuated measles-mumps-rubella-varicella vaccine and Baxter’s Neisseria meningitidis C conjugate vaccine versus separate administration of each of the vaccines in healthy children aged 12 through 23 months. - MMRV-060Active immunization of healthy children during their second year of life against measles, mumps, rubella, varicella and Neisseria meningitidis C diseases
EUCTR2008-003318-81-DEGlaxoSmithKline Biologicals708
进行中(未招募)
1 期
This study compares clinically and microscopically the response to two treatments, a steroid in cream and a foam that contains a steroid and a vitamin D analogue in patients with plaque psoriasis.Plaque psoriasis
EUCTR2017-004451-24-ESFundació Clínic per a la Reserca Biomèdica36
进行中(未招募)
1 期
A study to evaluate the impact of the change of antiretroviral treatment from dual therapy to triple therapy on inflammation in HIV+ patients.
EUCTR2019-000199-41-ESFundación SEIMC-GESIDA234
进行中(未招募)
1 期
Study to evaluate the impact of early treatment with a budesonide / formoterol versus standard of care on the evolution of the disease in vulnerable patients with COVID-19: INHALAVID TrialEnfermedad en pacientes vulnerables con COVID-19MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2020-005280-31-ESFundació Eurecat200
进行中(未招募)
4 期
Comparison of combination of Diclofenac, Paracetamol, Trypsin, and Chymotrypsin versus combination of Diclofenac and Paracetamol in patient with soft tissue enjury.
CTRI/2021/01/030508Cachet Pharmaceutical Pvt Ltd220
Randomized study of three treatment arms; Colon... | 临床试验